These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

700 related articles for article (PubMed ID: 25703567)

  • 1. Heterogeneity in tuberculosis pathology, microenvironments and therapeutic responses.
    Lenaerts A; Barry CE; Dartois V
    Immunol Rev; 2015 Mar; 264(1):288-307. PubMed ID: 25703567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity in tuberculosis.
    Cadena AM; Fortune SM; Flynn JL
    Nat Rev Immunol; 2017 Nov; 17(11):691-702. PubMed ID: 28736436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse models of human TB pathology: roles in the analysis of necrosis and the development of host-directed therapies.
    Kramnik I; Beamer G
    Semin Immunopathol; 2016 Mar; 38(2):221-37. PubMed ID: 26542392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of host and microbial determinants in individuals with latent tuberculosis infection using a human granuloma model.
    Guirado E; Mbawuike U; Keiser TL; Arcos J; Azad AK; Wang SH; Schlesinger LS
    mBio; 2015 Feb; 6(1):e02537-14. PubMed ID: 25691598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host-directed therapy targeting the Mycobacterium tuberculosis granuloma: a review.
    Kiran D; Podell BK; Chambers M; Basaraba RJ
    Semin Immunopathol; 2016 Mar; 38(2):167-83. PubMed ID: 26510950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TB drug development: immunology at the table.
    Nathan C; Barry CE
    Immunol Rev; 2015 Mar; 264(1):308-18. PubMed ID: 25703568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A computational tool integrating host immunity with antibiotic dynamics to study tuberculosis treatment.
    Pienaar E; Cilfone NA; Lin PL; Dartois V; Mattila JT; Butler JR; Flynn JL; Kirschner DE; Linderman JJ
    J Theor Biol; 2015 Feb; 367():166-179. PubMed ID: 25497475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculosis as a three-act play: A new paradigm for the pathogenesis of pulmonary tuberculosis.
    Hunter RL
    Tuberculosis (Edinb); 2016 Mar; 97():8-17. PubMed ID: 26980490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host-Pathogen Interaction as a Novel Target for Host-Directed Therapies in Tuberculosis.
    Abreu R; Giri P; Quinn F
    Front Immunol; 2020; 11():1553. PubMed ID: 32849525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Latent TB Infection (LTBI) - Mycobacterium tuberculosis pathogenesis and the dynamics of the granuloma battleground.
    Rao M; Ippolito G; Mfinanga S; Ntoumi F; Yeboah-Manu D; Vilaplana C; Zumla A; Maeurer M
    Int J Infect Dis; 2019 Mar; 80S():S58-S61. PubMed ID: 30822547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incipient and Subclinical Tuberculosis: a Clinical Review of Early Stages and Progression of Infection.
    Drain PK; Bajema KL; Dowdy D; Dheda K; Naidoo K; Schumacher SG; Ma S; Meermeier E; Lewinsohn DM; Sherman DR
    Clin Microbiol Rev; 2018 Oct; 31(4):. PubMed ID: 30021818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic Heterogeneity in Mycobacterium tuberculosis.
    Dhar N; McKinney J; Manina G
    Microbiol Spectr; 2016 Nov; 4(6):. PubMed ID: 27837741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The secret trumps, impelling the pathogenicity of tubercle bacilli.
    Cardona PJ; Ivanyi J
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 1():14-9. PubMed ID: 21420562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adventures within the speckled band: heterogeneity, angiogenesis, and balanced inflammation in the tuberculous granuloma.
    Matty MA; Roca FJ; Cronan MR; Tobin DM
    Immunol Rev; 2015 Mar; 264(1):276-87. PubMed ID: 25703566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissecting host factors that regulate the early stages of tuberculosis infection.
    Agrawal N; Bhattacharyya C; Mukherjee A; Ullah U; Pandit B; Rao KVS; Majumder PP
    Tuberculosis (Edinb); 2016 Sep; 100():102-113. PubMed ID: 27553417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Floating between the poles of pathology and protection: can we pin down the granuloma in tuberculosis?
    Reece ST; Kaufmann SH
    Curr Opin Microbiol; 2012 Feb; 15(1):63-70. PubMed ID: 22074861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Latent tuberculosis: what the host "sees"?
    Gideon HP; Flynn JL
    Immunol Res; 2011 Aug; 50(2-3):202-12. PubMed ID: 21717066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathology and immune reactivity: understanding multidimensionality in pulmonary tuberculosis.
    Dorhoi A; Kaufmann SH
    Semin Immunopathol; 2016 Mar; 38(2):153-66. PubMed ID: 26438324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-Human Primate Models of Tuberculosis.
    Peña JC; Ho WZ
    Microbiol Spectr; 2016 Aug; 4(4):. PubMed ID: 27726820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.